Karen Quillen, MD

Professor, Pathology & Laboratory Medicine

Karen Quillen
617.358.2694
670 Albany St .

Other Positions

  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Queen's University, MD
  • Harvard University, AB

Publications

  • Published on 8/20/2023

    Sarosiek S, Lee MH, Doros G, Edwards CV, Quillen K, Brauneis D, Shelton AC, Sanchorawala V, Sloan JM. Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study. Transplant Cell Ther. 2023 Nov; 29(11):695.e1-695.e7. PMID: 37607644.

    Read at: PubMed
  • Published on 8/12/2022

    Hassan H, Verma K, Ferri G, Brauneis D, Quillen K, Sloan JM, Sanchorawala V, Edwards CV. Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Transplant Cell Ther. 2022 Nov; 28(11):761.e1-761.e7. PMID: 35970300.

    Read at: PubMed
  • Published on 8/31/2021

    Shevtsov A, Parada M, Burks EJ, Quillen K. Peripheral blood smear and hemoglobin electrophoresis of unsuspected hemoglobin Bart's hydrops fetalis in a newborn. Int J Lab Hematol. 2022 Feb; 44(1):53-54. PMID: 34464034.

    Read at: PubMed
  • Published on 7/14/2021

    Kritselis M, Yambayev I, Prilutskiy A, Shevtsov A, Vadlamudi C, Zheng H, Elsadwai M, Ma L, Aniskovich E, Kataria Y, Higgins S, Sarita-Reyes C, Zuo T, Zhao Q, Quillen K, Burks EJ. Distinctive pseudopalisaded histiocytic hyperplasia characterizes the transition of exudative to proliferative phase of diffuse alveolar damage in patients dying of COVID-19. Hum Pathol. 2021 10; 116:49-62. PMID: 34273395.

    Read at: PubMed
  • Published on 4/9/2021

    Yuen RR, Steiner D, Pihl RMF, Chavez E, Olson A, Smith EL, Baird LA, Korkmaz F, Urick P, Sagar M, Berrigan JL, Gummuluru S, Corley RB, Quillen K, Belkina AC, Mostoslavsky G, Rifkin IR, Kataria Y, Cappione AJ, Gao W, Lin NH, Bhadelia N, Snyder-Cappione JE. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19 via Multi-Parameter Detection. Front Immunol. 2021; 12:614676. PMID: 33897682.

    Read at: PubMed
  • Published on 3/1/2021

    Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2021 03 01; 41(1):e77-e78. PMID: 32235225.

    Read at: PubMed
  • Published on 9/8/2020

    Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM, Quillen K, Burks EJ. SARS-CoV-2 Infection-Associated Hemophagocytic Lymphohistiocytosis. Am J Clin Pathol. 2020 09 08; 154(4):466-474. PMID: 32681166.

    Read at: PubMed
  • Published on 9/1/2020

    Sarosiek S, Zheng L, Sloan JM, Quillen K, Brauneis D, Sanchorawala V. Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis. Blood Cancer J. 2020 09 01; 10(8):88. PMID: 32873776.

    Read at: PubMed
  • Published on 10/4/2019

    Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319. PMID: 31489689.

    Read at: PubMed
  • Published on 5/9/2019

    Singh P, Chen H, Gordon CE, Ghai S, Sloan JM, Quillen K, Moradi S, Chitalia V, Gautam A, Henderson J, Francis JM. Monoclonal IgG4/2? Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation. Kidney Med. 2019 May-Jun; 1(3):139-143. PMID: 32734194.

    Read at: PubMed

View 76 more publications: View full profile at BUMC

View all profiles